EPI and Health Outcomes
The following describes some of the ongoing research in the Division of Immunology and Rheumatology.
Dr. Chung is the founder and director of the Stanford Scleroderma Center of Excellence. Dr. Chung leads a team of over 15 clinicians and researchers focusing on systemic sclerosis (SSc) patient care and research. In addition to providing exceptional care, the center maintains a detailed clinical database and biorepository of tissue samples that are used in collaborative studies. Dr. Chung’s particular research areas of interest include epidemiologic, outcomes, and translational studies on cutaneous, pulmonary, musculoskeletal, gastrointestinal, and reproductive complications of SSc and related connective tissue diseases. The center also conducts industry-sponsored and investigator-initiated clinical trials of novel therapeutic agents for the treatment of SSc and related diseases. Clinical trials include investigations of novel therapeutic agents for the treatment of Raynaud’s phenomenon, cutaneous sclerosis, calcinosis, interstitial lung disease, digital ulcers, pulmonary arterial hypertension, and inflammatory myopathies.
You are free to use copy and redistribute the Health Assessment Questionnaire (HAQ) for any purpose. You must include the following text:
“Developed in the lab of Professor James F. Fries, MD.
© 1978-2018 The Board of Trustees of the Leland Stanford Junior University"